Sally Beauty Holdings, Inc.: Form 10-Q for the period ended Dec 31, 2022
Filed with the SEC on Feb 2, 2023 and accepted by EDGAR at Feb 2, 2023, 21:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-10-01 to 2022-12-31 | $957.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-10-01 to 2022-12-31 | $468.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-10-01 to 2022-12-31 | $488.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2022-10-01 to 2022-12-31 | $391.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-10-01 to 2022-12-31 | $86.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-10-01 to 2022-12-31 | $17.9m | us-gaap:InterestExpense |
| Income tax | 3 months2022-10-01 to 2022-12-31 | $18.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-10-01 to 2022-12-31 | $50.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-10-01 to 2022-12-31 | $0.46 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-10-01 to 2022-12-31 | $0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-10-01 to 2022-12-31 | 109,460,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-10-01 to 2022-12-31 | $55.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-10-01 to 2022-12-31 | $25.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $99.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $1.22bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $2.67bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $677.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $2.30bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $1.09bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2022-12-31 | $373.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-23-001405. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.